CASI Pharma (CASI) Misses Q3 EPS by 67c
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Astrana Health (ASTH) Mentioned as short at Glass House
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Super Micro Computer stock rises on AI server optimism
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
